60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
0.973
-0.007 (-0.68%)
At close: Dec 5, 2025, 4:00 PM EST
0.990
+0.017 (1.72%)
After-hours: Dec 5, 2025, 7:41 PM EST
SXTP Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 1.36 | 0.68 | 0.25 | 0.51 | 6.35 | 2.55 |
| Revenue Growth (YoY) | 202.10% | 168.70% | -50.40% | -91.95% | 149.18% | - |
| Cost of Revenue | 0.78 | 3.61 | 0.67 | 0.96 | 6.36 | 1.51 |
| Gross Profit | 0.59 | -2.93 | -0.41 | -0.45 | -0.01 | 1.04 |
| Selling, General & Admin | 6.41 | 5.02 | 4.24 | 1.3 | 1.12 | 1.46 |
| Research & Development | 2.08 | 1.76 | 0.5 | - | - | - |
| Operating Expenses | 8.49 | 6.78 | 4.74 | 1.3 | 1.12 | 1.46 |
| Operating Income | -7.91 | -9.71 | -5.15 | -1.75 | -1.12 | -0.42 |
| Interest Expense | -0.01 | -0.01 | -2.29 | -3.99 | -3.17 | -2.63 |
| Other Non Operating Income (Expenses) | -0.06 | 1.77 | -0.47 | -0.56 | -0 | - |
| EBT Excluding Unusual Items | -7.98 | -7.96 | -7.91 | -6.3 | -4.3 | -3.05 |
| Other Unusual Items | - | - | 4.1 | 0.12 | 0.04 | - |
| Pretax Income | -7.98 | -7.96 | -3.81 | -6.18 | -4.26 | -3.05 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings From Continuing Operations | -7.98 | -7.96 | -3.81 | -6.18 | -4.26 | -3.05 |
| Minority Interest in Earnings | 0.01 | 0.01 | 0.05 | -0 | 0.01 | 0.01 |
| Net Income | -7.97 | -7.95 | -3.77 | -6.18 | -4.25 | -3.03 |
| Preferred Dividends & Other Adjustments | 0.5 | 0.48 | 0.22 | - | - | - |
| Net Income to Common | -8.48 | -8.43 | -3.99 | -6.18 | -4.25 | -3.03 |
| Shares Outstanding (Basic) | 2 | 0 | 0 | 0 | 19 | - |
| Shares Outstanding (Diluted) | 2 | 0 | 0 | 0 | 19 | - |
| Shares Change (YoY) | 672.59% | 585.50% | 68.05% | -99.79% | - | - |
| EPS (Basic) | -4.57 | -18.55 | -60.11 | -156.65 | -0.23 | - |
| EPS (Diluted) | -4.57 | -18.55 | -60.11 | -156.65 | -0.23 | - |
| Free Cash Flow | -6.85 | -5.75 | -4.6 | -1.01 | -0.65 | -0.17 |
| Free Cash Flow Per Share | -3.70 | -12.65 | -69.38 | -25.59 | -0.04 | - |
| Gross Margin | 42.92% | - | -163.01% | -87.39% | -0.14% | 40.78% |
| Operating Margin | -579.24% | -1425.85% | -2032.78% | -342.41% | -17.69% | -16.40% |
| Profit Margin | -620.95% | -1237.32% | -1572.10% | -1209.23% | -66.93% | -119.00% |
| Free Cash Flow Margin | -502.20% | -844.19% | -1814.28% | -197.57% | -10.27% | -6.56% |
| EBITDA | -7.83 | -9.66 | -5.1 | -1.72 | -1.09 | -0.39 |
| EBITDA Margin | - | - | - | - | -17.21% | -15.31% |
| D&A For EBITDA | 0.08 | 0.05 | 0.05 | 0.03 | 0.03 | 0.03 |
| EBIT | -7.91 | -9.71 | -5.15 | -1.75 | -1.12 | -0.42 |
| EBIT Margin | - | - | - | - | -17.69% | -16.40% |
Source: S&P Capital IQ. Standard template.
Financial Sources.